Clopidogrel

An antiplatelet agent acts mainly by inhibiting the ADP-mediated platelet aggregation pathway and has been shown to reduce mortality in patients with acute myocardial infarction. It decreases the risk of ischemic stroke, MI, and vascular death in patients with prior cardiovascular disease. It usefully potentiates the action of aspirin
Contraindications: Active bleeding–eg, PUD, intracranial hemorrhage, or Patients at risk for bleeding due to trauma, surgery, or other drug therapy Adverse events: Dyspepsia, purpura, diarrhea, rash, intracranial hemorrhage, neutropenia.